- WRBM SASsenior editor, 2008 - present
- Marketletter Publicationsreporter, 2005 - 2008
- Procter & Gamblemolecular biologist, 2004 - 2005
- Leatherhead Food Internationalscientist, 2003 - 2004
- University of Exeterbioinformatics, 2001 - 2002
- University of Warwickvirology and microbiology, 1997 - 2000
Lower number of animals used in drug R&D in 2011 says new EC report
Fewer animals were used to test the safety of life saving drugs in Europe in 2011 than in previous years according to the sixth edition of a
From China to the Culture Dish: A Brief History of the CHO cell line
Scientists say the Chinese hamster genome published last month will help biomanufacturers develop better CHO cell lines.
Aussie Team Uses Hot Ethanol to Make Smaller API Particles
Appreciating warm alcohol, like being rubbish at cricket, is no longer a solely British preserve with researchers in Australia developing a
Technology News Is Vital for BioPharmas MIT Prof Tells BioPharma-Reporte...
Keeping up with the latest technology news is a must for biomanufacturers according to an MIT Professor who told BioPharma-Reporter.com new
Pii named as manufacturer of drug withdrawn by Sun Pharma
US CMO Pharmaceutics International (Pii) has been named as the manufacturer of the cranial bleeding treatment voluntarily withdrawn by India
CDSCO can inspect trial sites and seize docs unannounced under new guide...
Inspectors will be able to visit clinical trial sites unannounced and seize records under new draft guidelines issued by the Indian Central
SFDA yet to publish excipient list as implementation date for GMP nears
Chinese regulators have just 11 days left to define which excipients must be licensed or require DMFs under new quality regulations due to b
BASF sees synergies between new acquisition Pronova and Equateq
BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.
Odin likely to accept revised offer for Pronova says BASF
German chemicals giant BASF expects its revised takeover bid for Norwegian omega-3 API manufacturer Pronova Biopharma ASA to be accepted by
Granules India cites rising China API and intermediates prices as Q1 driver
Granules India saw API sales rocket in the fiscal first quarter due – according to the firm – to an efficiency drive and the impact of risin
Language skills and local knowledge a must for BPO success in Asia says ...
Multilingual ‘magic’ and cultural knowledge are the keys to business process outsourcing (BPO) success in North Asia according to Quintiles.
Precos to expand cancer model portfolio thanks to new HTA license
Precos will expand its portfolio of preclinical cancer models after being licensed to store and handle human tissue by the UK’s HTA.
New Herceptin formulation allows delivery via injection
A new formulation of Genetech’s breast cancer drug Herceptin means patients could soon receive treatment via injection, rather than time con
FDA to develop GDUFA self-identification database; warns about ANDA back...
The US FDA plans to establish a new database for manufacturing facilities required to ‘self-identify’ under new GDUFA laws.
GE and iBio designing plant-cell based vaccine facility
GE Healthcare has started designing a vaccine manufacturing facility a drug company, just days after expanding its collaboration with plant-
BPTF says FDA safety and innovation act is good for safety and US industry
SOCMA’s BPTF says new fee laws under the FDA Safety and Innovation Act will improve drug quality and boost US manufacturing sector.
Charles River talks up unity, ‘no comments’ takeover reports
Charles River’s CEO has reiterated the importance of integrating its research models and preclinical units but refused to discuss takeover r